168 related articles for article (PubMed ID: 32943880)
1. Bone Marrow Stromal Antigen 2 is a Potential Unfavorable Prognostic Factor for High-Grade Glioma.
Shi H; Luo K; Huang W
Onco Targets Ther; 2020; 13():8723-8734. PubMed ID: 32943880
[TBL] [Abstract][Full Text] [Related]
2. SCAMP3 Promotes Glioma Proliferation and Indicates Unfavorable Prognosis via Multiple Pathways.
Li C; Zhang Z; Lv P; Zhan Y; Zhong Q
Onco Targets Ther; 2020; 13():3677-3687. PubMed ID: 32431518
[TBL] [Abstract][Full Text] [Related]
3. BST2 Promotes Tumor Growth via Multiple Pathways in Hepatocellular Carcinoma.
Xu X; Wang Y; Xue F; Guan E; Tian F; Xu J; Zhang H
Cancer Invest; 2020 May; 38(5):329-337. PubMed ID: 32427495
[TBL] [Abstract][Full Text] [Related]
4. The expression of BST2 in human and experimental mouse brain tumors.
Wainwright DA; Balyasnikova IV; Han Y; Lesniak MS
Exp Mol Pathol; 2011 Aug; 91(1):440-6. PubMed ID: 21565182
[TBL] [Abstract][Full Text] [Related]
5. High expression of GLO1 indicates unfavorable clinical outcomes in glioma patients.
Tian X; Wang Y; Ding X; Cheng W
J Neurosurg Sci; 2022 Jun; 66(3):228-233. PubMed ID: 31738028
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review).
Yu H; Bian Q; Wang X; Wang X; Lai L; Wu Z; Zhao Z; Ban B
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38240088
[TBL] [Abstract][Full Text] [Related]
7. Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.
Sayeed A; Luciani-Torres G; Meng Z; Bennington JL; Moore DH; Dairkee SH
PLoS One; 2013; 8(6):e67191. PubMed ID: 23840623
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
9. High expression of mitogen-activated and stress-activated protein kinase 1 indicates poor prognosis in patients with glioma.
Li H; Zhao C; Xu M; Yin M
Neuroreport; 2018 Oct; 29(15):1249-1255. PubMed ID: 30020192
[TBL] [Abstract][Full Text] [Related]
10. BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer.
He X; Chen H; Zhong X; Wang Y; Hu Z; Huang H; Zhao S; Wei P; Shi D; Li D
Int J Biol Sci; 2023; 19(1):331-345. PubMed ID: 36594082
[No Abstract] [Full Text] [Related]
11. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
Cai D; Cao J; Li Z; Zheng X; Yao Y; Li W; Yuan Z
BMC Cancer; 2009 Apr; 9():102. PubMed ID: 19338666
[TBL] [Abstract][Full Text] [Related]
12. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
Shan F; Shen S; Wang X; Chen G
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.
Mukai S; Oue N; Oshima T; Mukai R; Tatsumoto Y; Sakamoto N; Sentani K; Tanabe K; Egi H; Hinoi T; Ohdan H; Yasui W
Ann Surg Oncol; 2017 Feb; 24(2):594-602. PubMed ID: 26832883
[TBL] [Abstract][Full Text] [Related]
14. Tac2-N Promotes Glioma Proliferation and Indicates Poor Clinical Outcomes.
Dou Y; Xu H; Wu X; Liu P
Tohoku J Exp Med; 2021 Nov; 255(3):247-256. PubMed ID: 34840225
[TBL] [Abstract][Full Text] [Related]
15. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma.
Pham QT; Oue N; Yamamoto Y; Shigematsu Y; Sekino Y; Sakamoto N; Sentani K; Uraoka N; Tiwari M; Yasui W
Anticancer Res; 2017 Jun; 37(6):2853-2860. PubMed ID: 28551621
[TBL] [Abstract][Full Text] [Related]
16. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients.
Men D; Liang Y; Chen L
Cancer Epidemiol; 2014 Apr; 38(2):152-6. PubMed ID: 24559637
[TBL] [Abstract][Full Text] [Related]
18. BST2 promotes growth and induces gefitinib resistance in oral squamous cell carcinoma via regulating the EGFR pathway.
Jin H; Zhang L; Wang S; Qian L
Arch Med Sci; 2021; 17(6):1772-1782. PubMed ID: 34900059
[TBL] [Abstract][Full Text] [Related]
19. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.
Yokoyama T; Enomoto T; Serada S; Morimoto A; Matsuzaki S; Ueda Y; Yoshino K; Fujita M; Kyo S; Iwahori K; Fujimoto M; Kimura T; Naka T
Int J Cancer; 2013 Jan; 132(2):472-84. PubMed ID: 22729361
[TBL] [Abstract][Full Text] [Related]
20. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
